Opioid bill awaits president’s signature

Last week the Senate voted 98-1 to pass the major opioid legislative package it had negotiated with the House. The bill now awaits President Trump’s signature.

The House and Senate mostly agreed on major provisions of the legislation, however language that would let Medicare pay more for opioid alternatives that treat post-surgical pain did not make the final cut. Also not included was a fiscal offset that would have saved government funds by requiring employer-paid plans to cover more care for end-stage renal disease.

Click here to view a comparison of select provisions of the House and Senate bills and what was included in the final opioid bill.